This page shows the latest Immodulon news and features for those working in and with pharma, biotech and healthcare.
Independent biopharmaceutical company Immodulon Therapeutics has appointed Dr Jerome Zeldis as its executive vice chairman. ... the continued clinical development and commercialisation of Immodulon’s lead immunotherapy compound IMM-101”.
Anthony Bolton and Sir Simon Robertson join the biopharma firm. Immodulon Therapeutics, a privately held, late-stage biopharmaceutical company focused on immuno-oncology has made two new senior appointments to its ... Anthony Bolton, one of the UK's most
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...